MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease (NCT05264051)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• The University of Chicago — Chicago, Illinois

📞 Contact the Study Coordinator

Phone: (847) 373-2360

Email: Omar.Jamil@uchospitals.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Liver Diseases

• Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use — San Francisco, California
• Liver Cancer Prevention Randomized Control Trial — Houston, Texas
• RESTORE Declined Livers Study — St Louis, Missouri
• Liver Micro Flow - MRI — Madison, Wisconsin
• The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial — Chicago, Illinois

Explore by condition: All Liver Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.